CXCR4 and neoplasm: We assayed its selectivity and CXCR4 dependence regarding tumor tissue uptake, internalization in CXCR4‐overexpressing MetSCs (target cells), intracellular release of the cytotoxic drug FdU, and selective CXCR4+ MetSC killing (Fig 2A).